Health technology assessment of biosimilars worldwide: a scoping review

Health technology assessment of biosimilars worldwide: a scoping review

Abstract Background Health technology assessment (HTA) should provide an assessment of a technology’s effects on health and of the related social, economic, organisational and ethical issues. HTA reports on biosimilars can specifically assess their immunogenicity, their extrapolation to one or more...

Full description

Bibliographic Details
Main Authors: Bruna de Oliveira Ascef, Ana Carolina de Freitas Lopes, Patrícia Coelho de Soárez
Format: Article
Language:English
Published: BMC 2020-08-01
Series:Health Research Policy and Systems
Subjects:
Biosimilar pharmaceuticals
Technology assessment
Biomedical
Health policy
Evidence-based decisions
Online Access:http://link.springer.com/article/10.1186/s12961-020-00611-y

Internet

http://link.springer.com/article/10.1186/s12961-020-00611-y

Similar Items